GO:2000051 negative regulation of non-canonical Wnt signaling pathway: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000051 describes any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling, the beta-catenin-independent branch of Wnt signaling.
• Non-canonical Wnt signaling controls planar cell polarity, cell migration, and tissue morphogenesis, and its negative regulation is essential for normal development.
• Key negative regulators include EAF1 and EAF2/U19, which provide negative feedback on Wnt4 signaling, and Mcam, which inhibits macrophage-mediated mammary gland development through non-canonical Wnt signaling.
• Dysregulation of non-canonical Wnt signaling is implicated in cancer progression, including triple-negative breast cancer and colon cancer stem cell survival.
• The pathway is also linked to fibrosis, where Wnt/beta-catenin crosstalk influences disease progression and therapeutic targeting.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of negative regulators within this pathway.
Description
The Gene Ontology term GO:2000051, negative regulation of non-canonical Wnt signaling pathway, defines any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling. Non-canonical Wnt signaling comprises beta-catenin-independent branches, including the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway, which are critical for cell polarity, migration, and tissue morphogenesis during development. Unlike canonical Wnt signaling, which stabilizes beta-catenin to drive transcription, non-canonical pathways act through alternative effectors such as small GTPases and JNK to remodel the cytoskeleton and coordinate cell movements. Negative regulation of non-canonical Wnt signaling is essential for proper embryonic patterning and tissue homeostasis. For example, in sea urchin embryos, canonical and non-canonical Wnt signaling define the expression domains of distinct Frizzled receptors along the anterior-posterior axis, demonstrating that precise spatial and temporal control of both branches is required for normal development. In neural crest cells, the non-canonical Wnt-PCP pathway drives migration, and its negative regulation ensures that cells reach correct destinations without ectopic activation. Dysregulation of non-canonical Wnt signaling contributes to human disease. In triple-negative breast cancer, FOXC1-induced non-canonical WNT5A-MMP7 signaling promotes invasiveness, suggesting that negative regulators of this pathway could suppress metastasis. In colon cancer, non-canonical Hedgehog signaling positively regulates the WNT pathway and is required for cancer stem cell survival, highlighting complex crosstalk that negative regulators must balance. Understanding GO:2000051 therefore provides mechanistic insight into development and disease, and offers targets for therapeutic intervention.
negative regulation of non-canonical Wnt signaling pathway At A Glance
| GO ID | GO:2000051 |
|---|---|
| GO term | negative regulation of non-canonical Wnt signaling pathway |
| Ontology | biological_process |
| Synonym | negative regulation of beta-catenin-independent Wnt receptor signaling pathway; negative regulation of non-canonical Wnt-activated signaling pathway; negative regulation of non-canonical Wnt receptor signaling pathway; negative regulation of non-canonical Wnt receptor signalling pathway |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling, the beta-catenin-independent branch of Wnt signaling. |
| Related pathway | Non-canonical Wnt signaling includes planar cell polarity (PCP) and Wnt/Ca2+ branches. |
| Key negative regulators | EAF1, EAF2/U19, Mcam. |
| Disease relevance | Cancer (triple-negative breast cancer, colon cancer), fibrosis. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, imaging. |
What Is GO:2000051?
GO:2000051 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway. It encompasses molecular events that dampen beta-catenin-independent Wnt signaling, including the planar cell polarity pathway and Wnt/Ca2+ signaling. Synonyms include negative regulation of beta-catenin-independent Wnt receptor signaling pathway, negative regulation of non-canonical Wnt-activated signaling pathway, negative regulation of non-canonical Wnt receptor signaling pathway, and negative regulation of non-canonical Wnt receptor signalling pathway.
Why Is negative regulation of non-canonical Wnt signaling pathway Important in Cell Biology?
GO:2000051 is important because non-canonical Wnt signaling governs fundamental processes such as cell polarity, migration, and tissue morphogenesis, and its negative regulation ensures these processes are tightly controlled. Disruption of this regulation can lead to developmental defects and contribute to cancer progression, as seen in triple-negative breast cancer where non-canonical WNT5A-MMP7 signaling drives invasiveness. In colon cancer, non-canonical Hedgehog signaling positively regulates WNT to support cancer stem cell survival, underscoring the need for negative feedback mechanisms. Additionally, Wnt signaling crosstalk with beta-catenin is implicated in fibrosis progression, and therapeutic targeting of this axis is an active area of research. Thus, understanding negative regulation of non-canonical Wnt signaling provides critical insights into both normal biology and disease pathogenesis.
• Controls cell polarity and migration during embryonic development through the planar cell polarity pathway.
• Regulates neural crest migration, a key process in vertebrate development.
• Modulates expression domains of Frizzled receptors along the anterior-posterior axis in sea urchin embryos.
• Provides negative feedback on Wnt4 signaling via EAF1 and EAF2/U19.
• Influences mammary gland development through Mcam-mediated inhibition of macrophage-dependent non-canonical Wnt signaling.
• Dysregulation is linked to triple-negative breast cancer invasiveness via FOXC1-induced WNT5A-MMP7 signaling.
• Non-canonical Hedgehog signaling positively regulates WNT and is required for colon cancer stem cell survival.
• Wnt/beta-catenin crosstalk contributes to fibrosis progression, with therapeutic implications.
• Serves as a potential target for modulating metastasis and cancer stem cell maintenance.
• Provides a framework for understanding beta-catenin-independent Wnt functions in disease.
What Happens During negative regulation of non-canonical Wnt signaling pathway?
Initiation of negative feedback
In simple terms: The cell senses active non-canonical Wnt signaling and starts to shut it down.
Negative regulation of non-canonical Wnt signaling can be initiated by feedback mechanisms that respond to pathway activation. For example, EAF1 and EAF2/U19 provide negative feedback regulation of Wnt4 signaling, dampening the pathway after it has been activated. This feedback ensures that non-canonical Wnt signals do not persist excessively, which is critical for normal development.
Inhibition of receptor-proximal events
In simple terms: Proteins interfere with the receptors or immediate downstream messengers to block the signal.
Negative regulators can act at the level of Wnt receptors or their immediate effectors. In sea urchin embryos, the expression domains of Frizzled 5/8 and Frizzled 1/2/7 are defined by canonical and non-canonical Wnt signaling, indicating that receptor availability and activity are tightly controlled. Mcam inhibits macrophage-mediated development of the mammary gland through non-canonical Wnt signaling, suggesting that it modulates receptor-proximal events in this pathway.
Suppression of downstream effector activation
In simple terms: The signal is blocked before it can change cell behavior.
Negative regulation can prevent activation of downstream effectors such as small GTPases and JNK that mediate non-canonical Wnt-driven cytoskeletal changes. By inhibiting these effectors, negative regulators stop cell polarity and migration programs. In neural crest migration, the non-canonical Wnt-PCP pathway is essential, and its negative regulation prevents ectopic migration.
Crosstalk with other signaling pathways
In simple terms: Other pathways can turn down non-canonical Wnt signaling.
Negative regulation often occurs through crosstalk with other signaling cascades. Non-canonical Hedgehog signaling positively regulates the WNT pathway and is required for colon cancer stem cell survival, implying that interference with Hedgehog signaling could negatively regulate WNT. Similarly, PKCalpha-mediated nuclear translocation of cGAS stabilizes beta-catenin and drives metastasis, revealing crosstalk between immune signaling and Wnt pathways. These interactions provide multiple entry points for negative regulation.
Integration with developmental and homeostatic cues
In simple terms: The body's developmental signals help decide when to turn off the pathway.
Negative regulation of non-canonical Wnt signaling is integrated with developmental cues to shape tissues. In sea urchin embryos, the anterior-posterior axis is patterned by the complementary expression of Frizzled receptors, which depends on balanced canonical and non-canonical Wnt signaling. In mammary gland development, Mcam inhibits macrophage-mediated development through non-canonical Wnt signaling, highlighting how negative regulation coordinates tissue remodeling. In fibrosis, Wnt/beta-catenin signaling crosstalk influences disease progression, and therapeutic targeting by relaxin modulates this axis.
Key Genes Involved in GO:2000051 negative regulation of non-canonical Wnt signaling pathway
The following genes and proteins are experimentally implicated in negative regulation of non-canonical Wnt signaling or in the non-canonical Wnt pathway itself, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EAF1 | Provides negative feedback regulation of Wnt4 signaling | Studied for its role in dampening non-canonical Wnt4 signaling |
| EAF2/U19 | Provides negative feedback regulation of Wnt4 signaling | Key negative regulator of Wnt4 signaling |
| Mcam | Inhibits macrophage-mediated development of mammary gland through non-canonical Wnt signaling | Model for negative regulation in mammary gland development |
| WNT5A | Ligand in non-canonical Wnt signaling; FOXC1-induced WNT5A-MMP7 signaling regulates invasiveness | Target for triple-negative breast cancer invasiveness |
| MMP7 | Downstream effector of WNT5A in triple-negative breast cancer | Marker of invasive potential |
| FOXC1 | Induces non-canonical WNT5A-MMP7 signaling | Transcription factor driving invasiveness |
| Frizzled 5/8 | Receptors whose expression domains are defined by Wnt signaling in sea urchin embryos | Model for receptor-level control of non-canonical Wnt |
| Frizzled 1/2/7 | Receptors whose expression domains are defined by Wnt signaling in sea urchin embryos | Model for receptor-level control of non-canonical Wnt |
| cGAS | PKCalpha-mediated nuclear translocation stabilizes beta-catenin and drives metastasis | Links immune signaling to Wnt/beta-catenin |
| PKCalpha | Mediates nuclear translocation of cGAS | Kinase involved in crosstalk with Wnt |
| beta-catenin | Stabilized by cGAS; involved in canonical Wnt but crosstalk with non-canonical | Central node in Wnt crosstalk |
| Hedgehog signaling components | Non-canonical Hedgehog signaling positively regulates WNT and is required for colon cancer stem cell survival | Crosstalk target in colon cancer |
| Relaxin | Therapeutic targeting of Wnt/beta-catenin signaling in fibrosis | Potential therapeutic for fibrosis |
| Wnt4 | Ligand whose signaling is negatively regulated by EAF1 and EAF2/U19 | Model for negative feedback |
| Planar cell polarity (PCP) components | Mediate non-canonical Wnt-PCP pathway in neural crest migration | Core machinery for cell polarity |
How Is negative regulation of non-canonical Wnt signaling pathway Regulated?
Negative regulation of non-canonical Wnt signaling is itself controlled by feedback loops and crosstalk. EAF1 and EAF2/U19 provide negative feedback on Wnt4 signaling, meaning that pathway activation induces its own dampening. Mcam inhibits macrophage-mediated mammary gland development through non-canonical Wnt signaling, indicating that cell-surface molecules can modulate the pathway in a context-dependent manner. Crosstalk with Hedgehog signaling, which positively regulates WNT in colon cancer stem cells, suggests that interfering with Hedgehog could negatively regulate WNT. Additionally, PKCalpha-mediated nuclear translocation of cGAS stabilizes beta-catenin, revealing an immune-related input that can influence Wnt signaling balance. In fibrosis, relaxin modulates Wnt/beta-catenin signaling, providing a therapeutic angle for regulation.
negative regulation of non-canonical Wnt signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FOXC1 / WNT5A / MMP7 | Triple-negative breast cancer invasiveness | Knockout or knockdown of FOXC1 in TNBC cell lines; overexpression of WNT5A |
| Hedgehog signaling components | Colon cancer stem cell survival | Knockout of Hedgehog pathway genes in colon cancer stem cell models |
| cGAS / PKCalpha / beta-catenin | Metastasis | Point mutation of cGAS nuclear localization signal; PKCalpha knockout |
| EAF1 / EAF2/U19 | Negative feedback on Wnt4 signaling | Knockout and overexpression in cell lines to assess Wnt4 pathway activity |
| Mcam | Mammary gland development | Knockout mouse models or mammary epithelial cell lines |
Cancer progression and metastasis
Dysregulation of non-canonical Wnt signaling is implicated in cancer. In triple-negative breast cancer, FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness, suggesting that loss of negative regulation contributes to metastasis. In colon cancer, non-canonical Hedgehog signaling positively regulates the WNT pathway and is required for the survival of cancer stem cells, highlighting a dependency on Wnt activity that negative regulators would normally restrain. Furthermore, PKCalpha-mediated nuclear translocation of cGAS stabilizes beta-catenin and drives metastasis, linking immune signaling to Wnt-driven malignancy.
Fibrosis
Wnt/beta-catenin signaling is involved in fibrosis progression, and its therapeutic targeting by relaxin has been explored. While this primarily concerns canonical Wnt, crosstalk with non-canonical branches may influence fibrotic remodeling. Negative regulation of non-canonical Wnt signaling could therefore be relevant to controlling fibrotic responses, though direct evidence for GO:2000051 in fibrosis remains to be fully established.
Developmental disorders
Proper negative regulation of non-canonical Wnt signaling is essential for embryonic development. In sea urchin embryos, the expression domains of Frizzled receptors along the anterior-posterior axis depend on balanced canonical and non-canonical Wnt signaling. In neural crest cells, the non-canonical Wnt-PCP pathway drives migration, and its misregulation could lead to developmental defects. Mcam inhibits macrophage-mediated mammary gland development through non-canonical Wnt signaling, indicating a role in tissue morphogenesis.
From negative regulation of non-canonical Wnt signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of EAF1/EAF2 increase non-canonical Wnt signaling? | CRISPR knockout of EAF1 or EAF2 in cell lines, followed by Wnt reporter assays |
| Does Mcam negatively regulate non-canonical Wnt in mammary development? | Mcam knockout mouse or mammary epithelial cell knockout |
| Does FOXC1-driven WNT5A signaling require negative regulation to prevent invasion? | FOXC1 knockout or WNT5A overexpression in triple-negative breast cancer cells |
| How does cGAS nuclear translocation affect beta-catenin stability? | Point mutation of cGAS nuclear localization signal; knock-in of tagged cGAS |
| What is the role of Frizzled receptor domains in non-canonical Wnt? | Knock-in of fluorescently tagged Frizzled receptors in sea urchin embryos |
| Can negative regulators of non-canonical Wnt suppress cancer stem cell survival? | Overexpression of negative regulators in colon cancer stem cell models |
How to Study the negative regulation of non-canonical Wnt signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on non-canonical Wnt signaling | Identify negative regulators |
| RNA-seq | Transcriptional changes upon perturbation | Profile Wnt target genes |
| Live-cell imaging | Cell migration and polarity dynamics | Study neural crest migration |
| Western blot | Protein levels of pathway components | Assess beta-catenin, PKCalpha, cGAS |
| Co-immunoprecipitation | Protein-protein interactions | Identify complexes with EAF1/EAF2 |
| Reporter assays | Wnt pathway activity | Measure non-canonical Wnt signaling |
| In situ hybridization | Spatial expression of Frizzled receptors | Map expression domains in embryos |
| Flow cytometry | Cell surface marker expression | Assess Mcam function |
CRISPR-based genetic screens
CRISPR knockout screens can identify genes whose loss enhances or suppresses non-canonical Wnt signaling. By targeting candidate negative regulators such as EAF1, EAF2, or Mcam, researchers can assess pathway activity using Wnt-responsive reporters. Library screening allows unbiased discovery of novel regulators within GO:2000051.
Transcriptomics and pathway profiling
RNA-seq can reveal changes in non-canonical Wnt target genes upon perturbation of negative regulators. For example, knockout of EAF1/EAF2 may alter Wnt4 target gene expression. Profiling Frizzled receptor expression domains in embryos can map spatial regulation.
Imaging and cell migration assays
Live-cell imaging of neural crest migration or planar cell polarity can quantify the effects of negative regulators on cell movement. Fluorescently tagged receptors or effectors allow visualization of pathway activity in real time.
Biochemical assays for pathway activity
Western blotting for beta-catenin, PKCalpha, or cGAS can assess crosstalk between non-canonical Wnt and other pathways. Co-immunoprecipitation can identify protein complexes involving negative regulators.
How CRISPR Can Be Used to Study GO:2000051 negative regulation of non-canonical Wnt signaling pathway
Knockout
CRISPR knockout of negative regulators such as EAF1, EAF2, or Mcam can test whether their loss increases non-canonical Wnt signaling. For example, EAF1/EAF2 knockout cells may show enhanced Wnt4 signaling, confirming their role in negative feedback. Mcam knockout in mammary epithelial cells can reveal its inhibitory role in non-canonical Wnt-dependent development.
Point Mutation
Point mutations can dissect specific residues required for negative regulation. For instance, mutating the nuclear localization signal of cGAS can prevent its nuclear translocation and alter beta-catenin stabilization, clarifying crosstalk mechanisms. Similarly, point mutations in Frizzled receptors can test their role in non-canonical Wnt signaling.
Knock-in
Knock-in of tagged or reporter alleles allows real-time monitoring of negative regulators. Tagging endogenous EAF1 or EAF2 with fluorescent proteins enables visualization of their dynamics during Wnt signaling. Knock-in of mutant beta-catenin can assess its contribution to crosstalk.
Overexpression
Overexpression of negative regulators can suppress non-canonical Wnt signaling and its downstream effects. For example, overexpressing EAF1 or EAF2 may dampen Wnt4-induced responses. Overexpressing Mcam could inhibit macrophage-mediated mammary development. Overexpression of FOXC1 or WNT5A can model cancer invasiveness and test whether negative regulators counteract it.
How EDITGENE Supports negative regulation of non-canonical Wnt signaling pathway Research
Researchers studying negative regulation of non-canonical Wnt signaling pathway-related genes often need to determine whether a candidate gene is causally involved in dampening the pathway, and CRISPR-based models provide the most direct approach. By systematically knocking out, mutating, or overexpressing genes such as EAF1, EAF2, Mcam, or FOXC1, scientists can establish causality and identify therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of non-canonical Wnt signaling pathway research.
Frequently Asked Questions About negative regulation of non-canonical Wnt signaling pathway
What is GO:2000051?
GO:2000051 is a Gene Ontology biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
What is negative regulation of non-canonical Wnt signaling pathway?
It refers to cellular mechanisms that dampen beta-catenin-independent Wnt signaling, including the planar cell polarity and Wnt/Ca2+ branches, to control cell polarity, migration, and development.
What genes are involved in negative regulation of non-canonical Wnt signaling?
Key genes include EAF1, EAF2/U19, Mcam, and components of crosstalk pathways such as Hedgehog signaling and cGAS/PKCalpha.
How does EAF1 regulate Wnt signaling?
EAF1, together with EAF2/U19, provides negative feedback regulation of Wnt4 signaling, dampening the pathway after activation.
What is the role of Mcam in non-canonical Wnt signaling?
Mcam inhibits macrophage-mediated development of the mammary gland through non-canonical Wnt signaling, acting as a negative regulator in this context.
Is non-canonical Wnt signaling involved in cancer?
Yes, non-canonical WNT5A-MMP7 signaling driven by FOXC1 regulates invasiveness in triple-negative breast cancer, and non-canonical Hedgehog signaling supports colon cancer stem cell survival.
How can I study negative regulation of non-canonical Wnt signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models combined with RNA-seq, imaging, and reporter assays are commonly used.
What are the synonyms for GO:2000051?
Synonyms include negative regulation of beta-catenin-independent Wnt receptor signaling pathway, negative regulation of non-canonical Wnt-activated signaling pathway, negative regulation of non-canonical Wnt receptor signaling pathway, and negative regulation of non-canonical Wnt receptor signalling pathway.
What diseases are linked to non-canonical Wnt signaling?
Cancers such as triple-negative breast cancer and colon cancer, as well as fibrosis, have been linked to dysregulated non-canonical Wnt signaling.
What model systems are used to study non-canonical Wnt signaling?
Sea urchin embryos, neural crest cells, mammary gland models, and cancer cell lines are commonly used to study non-canonical Wnt signaling and its negative regulation.
Conclusion
GO:2000051, negative regulation of non-canonical Wnt signaling pathway, is a critical biological process that ensures proper control of beta-catenin-independent Wnt signaling during development and tissue homeostasis. Its dysregulation contributes to cancer progression and fibrosis, making it a compelling area for therapeutic targeting. Advances in CRISPR-based models and screening technologies now allow precise interrogation of the genes and mechanisms that negatively regulate this pathway, accelerating both basic discovery and translational research.
References
- 1. Zhang Q et al.. 2026. PKCα-mediated nuclear translocation of cGAS stabilizes β-catenin and drives metastasis.. Mol Cell 86(12):2294-2308.e7 PMID: 42314650
- 2. Yang X et al.. 2024. Mcam inhibits macrophage-mediated development of mammary gland through non-canonical Wnt signaling.. Nat Commun 15(1):36 PMID: 38167296
- 3. Mayor R et al.. 2014. The role of the non-canonical Wnt-planar cell polarity pathway in neural crest migration.. Biochem J 457(1):19-26 PMID: 24325550
- 4. Regan JL et al.. 2017. Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells.. Cell Rep 21(10):2813-2828 PMID: 29212028
- 5. Han B et al.. 2018. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.. Oncogene 37(10):1399-1408 PMID: 29249801
- 6. Range RC. 2018. Canonical and non-canonical Wnt signaling pathways define the expression domains of Frizzled 5/8 and Frizzled 1/2/7 along the early anterior-posterior axis in sea urchin embryos.. Dev Biol 444(2):83-92 PMID: 30332609
- 7. Wan X et al.. 2010. Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19.. PLoS One 5(2):e9118 PMID: 20161747
- 8. Somanader DVN et al.. 2024. The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin.. Biochem Pharmacol 223:116130 PMID: 38490518
